A new trial has found that olmesartan, a commonly used drug for treating high blood pressure, can play an effective role in reducing coronary plaque.
Titled 'Impact of Olmesartan on progression of coronary atherosclerosis', the trial was conducted on 247 angina patients with native coronary artery lesions.
Coronary Artery Bypass Graft (CABG) - Triple Bypass Surgery
Triple bypass surgery, an open heart surgery involves grafting blood vessels from either the chest or leg onto 3 blocked blood vessels.
Advertisement
The scientists randomly assigned patients, to receive 20-40mg/day of olmesartan or control.
The participants were then treated with a combination of b-blockers, calcium channel blockers, diuretics, nitrates, glycemic control agents and/or statins per physician's guidance.
![Heart Attack]( "Heart Attack")
Heart attack is the death of the heart muscle due to loss of blood supply. Heart disease is the leading cause of death in the United States. Other names for heart attack include acute myocardial infarction, coronary thrombosis, and coronary occlusion.
Later, Serial Intravenous Ultrasound (IVUS) examinations were performed to assess the amount of coronary plaque before, and 14 months after the start of treatment.
Patient characteristics and all IVUS measurements were identical between the two groups, at the start of the trial. However, after 14 months, IVUS showed significant decreases in measurements of plaque volume in the olmesartan group, despite similar blood pressure readings.
Also, with the help of multivariate analysis, the researchers found that olmesartan administration was one of the factors that caused the decrease in plaque volume.
"Management of plaque is a key front in the war on sudden heart attack. These results suggest a positive role in potential plaque regression through the administration of olmesartan, an angiotension-II receptor blocking agent, for patients with stable angina pectoris," said Dr. Atsushi Hirohata, Cardiovascular Medicine, the Sakakibara Heart Institute of Okayama, Okayama, Japan and lead author of the study.
The study was presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).
Source: ANI
RAS/SK
Heart Attack
Heart attack is the death of the heart muscle due to loss of blood supply. Heart disease is the leading cause of death in the United States. Other names for heart attack include acute myocardial infarction, coronary thrombosis, and coronary occlusion.
Advertisement
Later, Serial Intravenous Ultrasound (IVUS) examinations were performed to assess the amount of coronary plaque before, and 14 months after the start of treatment.
Patient characteristics and all IVUS measurements were identical between the two groups, at the start of the trial. However, after 14 months, IVUS showed significant decreases in measurements of plaque volume in the olmesartan group, despite similar blood pressure readings.
Also, with the help of multivariate analysis, the researchers found that olmesartan administration was one of the factors that caused the decrease in plaque volume.
"Management of plaque is a key front in the war on sudden heart attack. These results suggest a positive role in potential plaque regression through the administration of olmesartan, an angiotension-II receptor blocking agent, for patients with stable angina pectoris," said Dr. Atsushi Hirohata, Cardiovascular Medicine, the Sakakibara Heart Institute of Okayama, Okayama, Japan and lead author of the study.
The study was presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).
Source: ANI
RAS/SK
Angioplasty - Animation
Arteries supplying the heart is sometimes blocked by plaque leading to heart attack.Angioplasty is a method by which a part of the blocked artery is expanded to place a stent.Once this is done normal blood flow resumes and the heart regains its normal function.
Advertisement
 Animation on Coronary Artery Bypass Surgery (CABG) - AnimationCoronary Artery Bypass Surgery (CABG) is performed to restore the blood supply to areas of heart that have been reduced or has no blood supply due to blockage in the artery. | Advertisement
|
Advertisement
Recommended Readings
Latest Drug News
Amoxicillin-clavulanate use in acute sinusitis patients is associated with a higher incidence of adverse events.
Professionals advocate for enhanced education of patients and caregivers, and creation of more effective child-resistant systems for monitoring ADHD medication.
In June, WHO raised concerns about 7 Indian cough syrups after complaints from several countries about contamination and health issues.
Women using hormonal contraception, along with their healthcare providers, should explore alternative pain relief options instead of NSAIDs.
The recently created assay identifies antipsychotic drugs present in sweat.
